Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | X4T99 | — |
Expired product used - Maladministration of an expired vaccine; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number X4T99, expiry date 30-SEP-2025) for prophylaxis. On 03-NOV-2025, the patient received Menveo. On 03-NOV-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: Expired product used - Maladministration of an expired vaccine). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 03-NOV-2025 The reporter called to report the maladministration of an expired Menveo one- vial vaccine. Registered nurse requested guidance from GlaxoSmithKline (already contacted the Centers for Disease Control and Prevention. The vaccination date, vaccine detail and patient demographics were obtained in this call. The Vaccine Administration Facility is the same as Primary Reporter